BRIEF-Bayer says Eylea receives EU recommendation for diabetic macular edema

June 27 Fri Jun 27, 2014 7:47am EDT

Related Topics

June 27 (Reuters) - Bayer AG : * Says aflibercept (Eylea) receives positive CHMP opinion for the treatment of visual impairment due to diabetic macular edema in EU

FILED UNDER: